Product Description
A 10 mM (5.0 mg in 855 μl), sterile-filtered solution of the HDR (homology-directed repair) enhancer L-755,507 (Cat. No. B1116) in anhydrous DMSO.
L-755,507 is a partial agonist of β3-adrenergic receptors (EC₅₀ = 0.43 nM). It displays >440-fold selectivity for β3- over β1- and β2-adrenoceptors (EC₅₀s = 580 and >10,000 nM, respectively). Enhances CRISPR-mediated homology-directed repair (HDR) efficiency in human induced pluripotent stem cells (iPSCs).
Biovision | B1873 | EZSolution™ L-755,507 DataSheet
Alternate Name/Synonyms: 4-[[(Hexylamino)carbonyl]amino]-N-[4-[2-[[(2S)-2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]phenyl]-benzenesulfonamide
Appearance: Liquid
Formulation: A 10 mM solution in DMSO
CAS Number: 159182-43-1
Structure Available?: Yes
Peptide sequence: N/A
Salt Form: No
Molecular Formula: C₃₀H₄₀N₄O₆S
Molecular Weight: 584.73
Cell-Permeable?: Yes
Purity: ≥98% by HPLC
Solubilities: N/A
Handling: Protect from air and light
Country of Origin: USA
Tag Line: A partial agonist of β3-adrenergic receptors and a HDR enhancer
MDL Number: N/A
PubChem CID: 9829836
SMILES: CCCCCCNC(=O)NC1=CC=C(C=C1)S(=O)(=O)NC2=CC=C(C=C2)CCNCC(COC3=CC=C(C=C3)O)O
InChi: InChI=1S/C30H40N4O6S/c1-2-3-4-5-19-32-30(37)33-24-10-16-29(17-11-24)41(38,39)34-25-8-6-23(7-9-25)18-20-31-21-27(36)22-40-28-14-12-26(35)13-15-28/h6-17,27,31,34-36H,2-5,18-22H2,1H3,(H2,32,33,37)/t27-/m0/s1
InChi Key: NYYJKMXNVNFOFQ-MHZLTWQESA-N